Aubrey de Grey
One of 100+ Minds on the Quest

Aubrey
de Grey

President & CSO, LEV Foundation
Biomedical gerontologist · Longevity escape velocity & the end of aging

Level 3 · RadicalRadical Life ExtensionDamage repair, gene and cell therapies, not wonder drugs, the road to longevity escape velocity.
Level 2 · UpgradesBiohacking UpgradesCombining interventions in his 1,000-mouse Robust Mouse Rejuvenation study, going where others won't.
The MissionCreating the MovementTurning public attitude, "longevity is not just an industry, it's a crusade."
Levels of Longevity Map Aubrey explores
1,000
Mice in his rejuvenation study
2022
Founded the LEV Foundation
12–15 yrs
His 50% escape-velocity window
Ending Aging
The book that reframed it
Who is Aubrey de Grey

The man who put ending aging on the map

Dr. Aubrey de Grey is one of the world's most influential biomedical gerontologists, more than anyone, the person who reframed aging as a problem we can actually solve. He is President and Chief Science Officer of the LEV Foundation (Longevity Escape Velocity), which he founded in 2022.

His central insight: aging is simply the lifelong accumulation of molecular and cellular damage: and damage can be repaired. Because small molecules can only slow the creation of new damage, he argues, truly defeating aging will require gene therapies and cell therapies, not wonder drugs. That conviction drives the LEV Foundation's landmark Robust Mouse Rejuvenation study: a 1,000-mouse experiment combining several interventions in middle-aged mice, in his words, "the single most important ones going on in the entire community."

He co-founded the SENS Research Foundation and wrote Ending Aging, the book that gave the field its damage-repair paradigm. He champions the idea of longevity escape velocity: the point at which medicine adds more than a year of healthy life for every year that passes.

Based in California's Bay Area for some fifteen years, he is blunt about what's missing: not the science, but the will and the funding. "Longevity is not just an industry," he says. "It's a crusade."

Aubrey de Grey is in our film Live Beyond: Father and Son on a Quest for Longevity and in Marek’s book Live Beyond: How to Win Your Longevity Game.

LEV Foundation · President & CSO Robust Mouse Rejuvenation SENS · co-founder Author · Ending Aging
Ending Aging, book cover
His book Ending Aging The rejuvenation breakthroughs that could reverse human aging in our lifetime, with Michael Rae (2007). Read the book ↗︎
Portrait of Dr. Aubrey de Grey, President of the LEV Foundation
President & CSO · LEV Foundation
Where we met

Where our quest began: Dublin, and a walk in California

Our whole journey began with Aubrey. We first met him at the Longevity Summit in Dublin: his conference, right as we were starting our quest around the world; he introduced us to scientists everywhere, who then welcomed us to their labs across the globe. Months later he took us on a walk through a park in Los Gatos, California, talking mouse rejuvenation and escape velocity. And in 2026 we were back in Dublin, this time with Marek on stage, as friends.

Longevity Summit Dublin
Ireland · 2023
Where the quest began. Aubrey's summit opened the door, and he introduced us to scientists all around the world.
Los Gatos
California, USA · 2024
A walk-and-talk through a California park, on his 1,000-mouse study, gene and cell therapies, and escape velocity.
Back in Dublin
Ireland · 2026
Together again at the summit, this time with Marek speaking, and Aubrey a friend cheering us on.

"Thank you for supporting us on this journey.", "Pleasure. Absolutely."

Marek Piotrowski & Aubrey de Grey, Los Gatos
From the articles
In his words

On aging, defeated

"We're not trying hard enough because we've had thousands of years of psychological denial."

Aubrey de Grey · Los Gatos, California

We have to always remember and emphasize that lifespan is a side effect of healthspan. You stay alive by staying healthy.

Aubrey de Grey

Small molecules, pharmaceuticals, are really only capable of modulating the creation of new damage. … There are plenty of aspects of aging which will simply never be addressed by small molecules and absolutely will need gene therapies or cell therapies.

Aubrey de Grey

Once we get those first 20 years or so, we will have done the hard part. I think that will actually get us to longevity escape velocity.

Aubrey de Grey

Big Pharma are not the bad guys. The FDA are not the bad guys. Even the government are not the bad guys. The bad guys really are us, the scientists, not making a sufficiently strong case for preventative provision.

Aubrey de Grey
In his own words

Straight from the interview

Pulled from our conversations with Aubrey, at the Longevity Summit in Dublin, and on a walk in Los Gatos, California, his science, his approach, and his message to the world.

Aubrey's view on longevity

Aging is repairable damage. Defeating it will take gene and cell therapies, not wonder drugs, to reach "longevity escape velocity."

"There are plenty of aspects of aging which will simply never be addressed by small molecules and absolutely will need gene therapies or cell therapies. So we have to include them now."

Los Gatos · 2024

How Aubrey does the science

His LEV Foundation runs the boldest experiment in the field, 1,000 mice, combining several therapies in middle age, going where others won't.

"It's looking damn good right now. It's looking like these combinations are adding up. They are doing better than any individual intervention does."

Robust Mouse Rejuvenation

His message to the world

The obstacle isn't the biology, it's a few thousand years of resigned acceptance. His call: be rational, and get to work.

"We need just to be more rational about this. People have been making excuses for aging, for not doing anything about aging, since the dawn of civilisation."

Los Gatos · 2024
Connect & follow

Explore Aubrey's work

From the conversation

Aubrey de Grey, in full

Video interview

The video interview is coming. Recorded interviews go live after the launch of the film & series Live Beyond.

Selected passages from our conversations with Dr. Aubrey de Grey, at the Longevity Summit in Dublin (2023) and on a walk in Los Gatos, California (2024).

On the 1,000-mouse experiment

Marek Piotrowski"Tell me, on your side, what happened over this last seven months in your research and in the work you're doing?"

Aubrey de Grey"It's really gone very well. So in August, when you came to Dublin, we were roughly six months into a huge 1,000-mouse experiment looking at the effects of combining a bunch of individually promising treatments in mice starting in middle age, when the mice were already two-thirds of the way through their normal lifespan, and seeing how much we could extend that lifespan, and of course healthy lifespan. … It's looking damn good right now. It's looking like these combinations are adding up. They are doing better than any individual intervention does, and so we are very encouraged. We definitely need to do more of these experiments with other interventions and with different combinations, but it's a great start. It's very promising."

On why it takes gene and cell therapies

Aubrey de Grey"The big thing that distinguishes our work from what's being done elsewhere in the world is that we are not restricting ourselves to things that can be supplied in the diet. … We have decided no, we need to go for gene therapies and cell therapies as well as compounds. So we're the only people doing that, and that's why we believe that our experiments are honestly the single most important ones going on in the entire community right now in terms of the amount of information that we can obtain per dollar. … We understand pretty well what aging is at this point, what it consists of in terms of the accumulation of various types of molecular and cellular damage, and therefore we know that small molecules, pharmaceuticals, are really only capable of modulating the creation of new damage. … There are plenty of aspects of aging which will simply never be addressed by small molecules and absolutely will need gene therapies or cell therapies. So we have to include them now."

On the tipping point

Aubrey de Grey"There's no one thing. There's no one magic funding bullet. We are just going to have to carry on doing what we've been doing for the past 20 years. You could call it repeat advertising, just basically telling the same story increasingly strongly, because every incremental step forward makes the story more persuasive, more compelling, and makes it less possible for people to say that the whole thing is science fiction and will never work. … There will come a point, a kind of tipping point, where people kind of feel that they know enough, and it will be a really sudden tipping point because of the whole herd mentality phenomenon, the fact that when a critical mass of opinion formers say something, then everybody follows. I think that may be only a couple of years away, but I've been saying that for a while. … Well, I don't do hope. I just plug away, and it takes as long as it takes."

On longevity escape velocity

Aubrey de Grey"Ten years is a very, very long time in biomedical technology, so it's extremely difficult for me to make any predictions that far out. I think that there's a strong probability that we will have basically solved the problem of aging in all but name. In other words, we will have passed this threshold of public attitudes to aging as a medical problem, in which there is a full-blown war on aging happening. I'm going to say an 80% chance that we will have reached that point 10 years from now. I think that there's a 20% chance, maybe 30%, that we will have actually reached longevity escape velocity 10 years from now. I'm saying that the 50% timeframe for that is between 12 and 15 years from now, so not much longer. And that means getting to the point where not only are we trying really hard as a species, humanity overall is trying really hard to fix aging, but actually we've succeeded to the point of postponing the health problems of late life by one year for every year that passes."

On pharma and prevention

Aubrey de Grey"The things that people say about the incentive structure of big pharma are oversimplifications. Big pharma wants to make money, that's for sure. But they are smart about looking at how to make money, both in the near term and in the longer term. … We, the medical profession, have not made the case for preventative medicine strongly enough. That's what has to change, and it will change. In due course, we will come to a point where people get that actually prevention is the way to go, and they're willing and eager to pay for it. And once they pay for it, Big Pharma will follow the money with a smile on their face. … Big Pharma are not the bad guys. The FDA are not the bad guys. Even the government are not the bad guys. The bad guys really are us, the scientists, not making a sufficiently strong case for preventative provision."

His message to the world

Aubrey de Grey"Different people need different things to inspire them. But essentially what I would say is that we need just to be more rational about this. People have been making excuses for aging, for not doing anything about aging, since the dawn of civilisation, because that's the only way that we could put aging out of our minds and walk away from the fact that there was nothing we could do about aging then. It's only in the past 25 years really, essentially since I came along, that that's changed. … We're now in a position where we do know how to develop technologies that will bring aging under comprehensive medical control, and we're not trying hard enough because we've had thousands of years of psychological denial. … We have to always remember and emphasize that lifespan is a side effect of healthspan. You stay alive by staying healthy."

Continue the quest

More minds on the quest

Aubrey de Grey explores Radical Life Extension on the Longevity Map, here are others on the same frontier, and the full cast of 100+.

Explore all 100+ experts